[{"id":96,"uid":"NPDI-6qDdNA","name":"Inhibition of P-gp by (-)epigallocatecin gallate","overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"NA","croIdentifier":null,"comment":null,"experimentalConditionsComment":null,"resultsComment":"In the presence of (-)-epigallocatechin gallate, the B-A transport of digoxin significantly decreased from 3.2%/h to 1.6%/h (P < 0.01 to 0.001). In the presence of (-)-epigallocatechin gallate, the B-A transport was greater than the A-B transport.","internalComment":null,"objectCompoundId":15,"objectMetaboliteCompoundId":null,"precipitantCompoundId":37,"cytochromeB5Id":null,"studyId":10,"experimentTypeId":5,"testSystemId":35,"ic50ShiftExperimentId":null,"controlDataExperimentId":87,"controlDataForExperimentId":87,"naturalProductSampleId":null,"experimentType.id":5,"experimentType.name":"In Vitro Transporter Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":true,"experimentType.isEnzyme":false,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000060","objectCompound.id":15,"objectCompound.name":"digoxin","objectCompound.unii":"73K4184T59","objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1326303,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1326303,"objectCompound.concept.conceptName":"Digoxin","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3407","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":37,"precipitantCompound.name":"(-)-epigallocatechin gallate","precipitantCompound.unii":null,"precipitantCompound.inChIKey":null,"precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":19,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":null,"objectMetaboliteCompound.name":null,"objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":null,"objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":null,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":null,"objectMetaboliteCompound.concept.conceptName":null,"objectMetaboliteCompound.concept.domainId":null,"objectMetaboliteCompound.concept.vocabularyId":null,"objectMetaboliteCompound.concept.conceptClassId":null,"objectMetaboliteCompound.concept.standardConcept":null,"objectMetaboliteCompound.concept.conceptCode":null,"objectMetaboliteCompound.concept.validStartDate":null,"objectMetaboliteCompound.concept.validEndDate":null,"objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":null,"enzymes.name":null,"enzymes.conceptId":null,"enzymes.experiment_enzyme_xref.enzymeId":null,"enzymes.experiment_enzyme_xref.experimentId":null,"transporters.id":11,"transporters.name":"P-gp (ABCB1)","transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":96,"transporters.experiment_transporter_xref.transporterId":11,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":10,"study.uid":"NPDI-7LwuzA","study.name":"Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein","study.napdiIdentifier":"PMID:26426900","study.overallSummary":"Green tea catechins inhibit the function of organic anion transporting polypeptides (OATPs) that mediate the uptake of a diverse group of drugs and endogenous compounds into cells. The present study was aimed at investigating the effect of green tea and its most abundant catechin epigallocatechin gallate (EGCG) on the transport activity of several drug transporters expressed in enterocytes, hepatocytes and renal proximal tubular cells such as OATPs, organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), and P-glycoprotein (P-gp). Uptake of the typical substrates metformin for OCTs and MATEs and bromosulphophthalein (BSP) and atorvastatin for OATPs was measured in the absence and presence of a commercially available green tea and EGCG. Transcellular transport of digoxin, a typical substrate of P-gp, was measured over 4 hours in the absence and presence of green tea or EGCG in Caco-2 cell monolayers. OCT1-, OCT2-, MATE1- and MATE2-K-mediated metformin uptake was significantly reduced in the presence of green tea and EGCG (P < 0.05). BSP net uptake by OATP1B1 and OATP1B3 was inhibited by green tea [IC50 2.6% (v/v) and 0.39% (v/v), respectively]. Green tea also inhibited OATP1B1- and OATP1B3-mediated atorvastatin net uptake with IC50 values of 1.9% (v/v) and 1.0% (v/v), respectively. Basolateral to apical transport of digoxin was significantly decreased in the presence of green tea and EGCG. These findings indicate that green tea and EGCG inhibit multiple drug transporters in vitro. Further studies are necessary to investigate the effects of green tea on prototoypical substrates of these transporters in humans, in particular on substrates of hepatic uptake transporters (e.g. statins) as well as on P-glycoprotein substrates.","study.pubmedId":26426900,"study.embaseId":null,"study.croIdentifier":"na","study.croInformation":"University of Erlangen Nuremberg","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"This is a study reported in the literature. The data was entered by JS and reviewed by JY.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProductSampleId":null,"study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProduct.binomial":"Camellia sinensis","study.naturalProduct.name":"Green tea","study.naturalProduct.itis":null,"study.naturalProduct.srs":"e9698137-24da-46f8-a70e-43e27691491f","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":35,"testSystem.name":"Caco-2 cells","testSystem.sortOrder":0,"testSystem.conceptId":null,"testSystem.categoryId":1,"testSystem.category.id":1,"testSystem.category.name":"Cell system","testSystem.category.sortOrder":1,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":87,"controlDataExperiment.uid":"NPDI-wur44g","controlDataExperiment.name":"P-gp mediated digoxin transport in Caco-2 cells","controlDataExperiment.overallEffect":1,"controlDataExperiment.isControlData":true,"controlDataExperiment.isIc50Shift":false,"controlDataExperiment.croCutoff":"NA","controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":"Digoxin transport in Caco-2 cells was greater in the B-A direction compared to in the A-B direction (3.2%/h vs. 0.74%/h). In the presence of the P-go inhibitor zosquidar (1 µM), net efflux of digoxin was completely inhibited.","controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":15,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":10,"controlDataExperiment.experimentTypeId":7,"controlDataExperiment.testSystemId":35,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":7,"controlDataExperiment.experimentType.name":"In Vitro Transporter Kinetics","controlDataExperiment.experimentType.isInVitro":true,"controlDataExperiment.experimentType.isTransporter":true,"controlDataExperiment.experimentType.isEnzyme":false,"controlDataExperiment.experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00005003","controlDataExperiment.objectCompound.id":15,"controlDataExperiment.objectCompound.name":"digoxin","controlDataExperiment.objectCompound.unii":"73K4184T59","controlDataExperiment.objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":1326303,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":11,"controlDataExperiment.transporters.name":"P-gp (ABCB1)","controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":11,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":3974,"experimentAnswers.text":"4 h","experimentAnswers.answerId":null,"experimentAnswers.experimentId":96,"experimentAnswers.questionId":6,"experimentAnswers.question.id":6,"experimentAnswers.question.text":"Incubation time","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":96,"uid":"NPDI-6qDdNA","name":"Inhibition of P-gp by (-)epigallocatecin gallate","overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"NA","croIdentifier":null,"comment":null,"experimentalConditionsComment":null,"resultsComment":"In the presence of (-)-epigallocatechin gallate, the B-A transport of digoxin significantly decreased from 3.2%/h to 1.6%/h (P < 0.01 to 0.001). In the presence of (-)-epigallocatechin gallate, the B-A transport was greater than the A-B transport.","internalComment":null,"objectCompoundId":15,"objectMetaboliteCompoundId":null,"precipitantCompoundId":37,"cytochromeB5Id":null,"studyId":10,"experimentTypeId":5,"testSystemId":35,"ic50ShiftExperimentId":null,"controlDataExperimentId":87,"controlDataForExperimentId":87,"naturalProductSampleId":null,"experimentType.id":5,"experimentType.name":"In Vitro Transporter Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":true,"experimentType.isEnzyme":false,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000060","objectCompound.id":15,"objectCompound.name":"digoxin","objectCompound.unii":"73K4184T59","objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1326303,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1326303,"objectCompound.concept.conceptName":"Digoxin","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3407","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":37,"precipitantCompound.name":"(-)-epigallocatechin gallate","precipitantCompound.unii":null,"precipitantCompound.inChIKey":null,"precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":19,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":null,"objectMetaboliteCompound.name":null,"objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":null,"objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":null,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":null,"objectMetaboliteCompound.concept.conceptName":null,"objectMetaboliteCompound.concept.domainId":null,"objectMetaboliteCompound.concept.vocabularyId":null,"objectMetaboliteCompound.concept.conceptClassId":null,"objectMetaboliteCompound.concept.standardConcept":null,"objectMetaboliteCompound.concept.conceptCode":null,"objectMetaboliteCompound.concept.validStartDate":null,"objectMetaboliteCompound.concept.validEndDate":null,"objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":null,"enzymes.name":null,"enzymes.conceptId":null,"enzymes.experiment_enzyme_xref.enzymeId":null,"enzymes.experiment_enzyme_xref.experimentId":null,"transporters.id":11,"transporters.name":"P-gp (ABCB1)","transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":96,"transporters.experiment_transporter_xref.transporterId":11,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":10,"study.uid":"NPDI-7LwuzA","study.name":"Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein","study.napdiIdentifier":"PMID:26426900","study.overallSummary":"Green tea catechins inhibit the function of organic anion transporting polypeptides (OATPs) that mediate the uptake of a diverse group of drugs and endogenous compounds into cells. The present study was aimed at investigating the effect of green tea and its most abundant catechin epigallocatechin gallate (EGCG) on the transport activity of several drug transporters expressed in enterocytes, hepatocytes and renal proximal tubular cells such as OATPs, organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), and P-glycoprotein (P-gp). Uptake of the typical substrates metformin for OCTs and MATEs and bromosulphophthalein (BSP) and atorvastatin for OATPs was measured in the absence and presence of a commercially available green tea and EGCG. Transcellular transport of digoxin, a typical substrate of P-gp, was measured over 4 hours in the absence and presence of green tea or EGCG in Caco-2 cell monolayers. OCT1-, OCT2-, MATE1- and MATE2-K-mediated metformin uptake was significantly reduced in the presence of green tea and EGCG (P < 0.05). BSP net uptake by OATP1B1 and OATP1B3 was inhibited by green tea [IC50 2.6% (v/v) and 0.39% (v/v), respectively]. Green tea also inhibited OATP1B1- and OATP1B3-mediated atorvastatin net uptake with IC50 values of 1.9% (v/v) and 1.0% (v/v), respectively. Basolateral to apical transport of digoxin was significantly decreased in the presence of green tea and EGCG. These findings indicate that green tea and EGCG inhibit multiple drug transporters in vitro. Further studies are necessary to investigate the effects of green tea on prototoypical substrates of these transporters in humans, in particular on substrates of hepatic uptake transporters (e.g. statins) as well as on P-glycoprotein substrates.","study.pubmedId":26426900,"study.embaseId":null,"study.croIdentifier":"na","study.croInformation":"University of Erlangen Nuremberg","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"This is a study reported in the literature. The data was entered by JS and reviewed by JY.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProductSampleId":null,"study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProduct.binomial":"Camellia sinensis","study.naturalProduct.name":"Green tea","study.naturalProduct.itis":null,"study.naturalProduct.srs":"e9698137-24da-46f8-a70e-43e27691491f","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":35,"testSystem.name":"Caco-2 cells","testSystem.sortOrder":0,"testSystem.conceptId":null,"testSystem.categoryId":1,"testSystem.category.id":1,"testSystem.category.name":"Cell system","testSystem.category.sortOrder":1,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":87,"controlDataExperiment.uid":"NPDI-wur44g","controlDataExperiment.name":"P-gp mediated digoxin transport in Caco-2 cells","controlDataExperiment.overallEffect":1,"controlDataExperiment.isControlData":true,"controlDataExperiment.isIc50Shift":false,"controlDataExperiment.croCutoff":"NA","controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":"Digoxin transport in Caco-2 cells was greater in the B-A direction compared to in the A-B direction (3.2%/h vs. 0.74%/h). In the presence of the P-go inhibitor zosquidar (1 µM), net efflux of digoxin was completely inhibited.","controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":15,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":10,"controlDataExperiment.experimentTypeId":7,"controlDataExperiment.testSystemId":35,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":7,"controlDataExperiment.experimentType.name":"In Vitro Transporter Kinetics","controlDataExperiment.experimentType.isInVitro":true,"controlDataExperiment.experimentType.isTransporter":true,"controlDataExperiment.experimentType.isEnzyme":false,"controlDataExperiment.experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00005003","controlDataExperiment.objectCompound.id":15,"controlDataExperiment.objectCompound.name":"digoxin","controlDataExperiment.objectCompound.unii":"73K4184T59","controlDataExperiment.objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":1326303,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":11,"controlDataExperiment.transporters.name":"P-gp (ABCB1)","controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":11,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":3975,"experimentAnswers.text":"5 µM","experimentAnswers.answerId":null,"experimentAnswers.experimentId":96,"experimentAnswers.questionId":11,"experimentAnswers.question.id":11,"experimentAnswers.question.text":"Object concentrations tested","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":96,"uid":"NPDI-6qDdNA","name":"Inhibition of P-gp by (-)epigallocatecin gallate","overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"NA","croIdentifier":null,"comment":null,"experimentalConditionsComment":null,"resultsComment":"In the presence of (-)-epigallocatechin gallate, the B-A transport of digoxin significantly decreased from 3.2%/h to 1.6%/h (P < 0.01 to 0.001). In the presence of (-)-epigallocatechin gallate, the B-A transport was greater than the A-B transport.","internalComment":null,"objectCompoundId":15,"objectMetaboliteCompoundId":null,"precipitantCompoundId":37,"cytochromeB5Id":null,"studyId":10,"experimentTypeId":5,"testSystemId":35,"ic50ShiftExperimentId":null,"controlDataExperimentId":87,"controlDataForExperimentId":87,"naturalProductSampleId":null,"experimentType.id":5,"experimentType.name":"In Vitro Transporter Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":true,"experimentType.isEnzyme":false,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000060","objectCompound.id":15,"objectCompound.name":"digoxin","objectCompound.unii":"73K4184T59","objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1326303,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1326303,"objectCompound.concept.conceptName":"Digoxin","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3407","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":37,"precipitantCompound.name":"(-)-epigallocatechin gallate","precipitantCompound.unii":null,"precipitantCompound.inChIKey":null,"precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":19,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":null,"objectMetaboliteCompound.name":null,"objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":null,"objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":null,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":null,"objectMetaboliteCompound.concept.conceptName":null,"objectMetaboliteCompound.concept.domainId":null,"objectMetaboliteCompound.concept.vocabularyId":null,"objectMetaboliteCompound.concept.conceptClassId":null,"objectMetaboliteCompound.concept.standardConcept":null,"objectMetaboliteCompound.concept.conceptCode":null,"objectMetaboliteCompound.concept.validStartDate":null,"objectMetaboliteCompound.concept.validEndDate":null,"objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":null,"enzymes.name":null,"enzymes.conceptId":null,"enzymes.experiment_enzyme_xref.enzymeId":null,"enzymes.experiment_enzyme_xref.experimentId":null,"transporters.id":11,"transporters.name":"P-gp (ABCB1)","transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":96,"transporters.experiment_transporter_xref.transporterId":11,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":10,"study.uid":"NPDI-7LwuzA","study.name":"Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein","study.napdiIdentifier":"PMID:26426900","study.overallSummary":"Green tea catechins inhibit the function of organic anion transporting polypeptides (OATPs) that mediate the uptake of a diverse group of drugs and endogenous compounds into cells. The present study was aimed at investigating the effect of green tea and its most abundant catechin epigallocatechin gallate (EGCG) on the transport activity of several drug transporters expressed in enterocytes, hepatocytes and renal proximal tubular cells such as OATPs, organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), and P-glycoprotein (P-gp). Uptake of the typical substrates metformin for OCTs and MATEs and bromosulphophthalein (BSP) and atorvastatin for OATPs was measured in the absence and presence of a commercially available green tea and EGCG. Transcellular transport of digoxin, a typical substrate of P-gp, was measured over 4 hours in the absence and presence of green tea or EGCG in Caco-2 cell monolayers. OCT1-, OCT2-, MATE1- and MATE2-K-mediated metformin uptake was significantly reduced in the presence of green tea and EGCG (P < 0.05). BSP net uptake by OATP1B1 and OATP1B3 was inhibited by green tea [IC50 2.6% (v/v) and 0.39% (v/v), respectively]. Green tea also inhibited OATP1B1- and OATP1B3-mediated atorvastatin net uptake with IC50 values of 1.9% (v/v) and 1.0% (v/v), respectively. Basolateral to apical transport of digoxin was significantly decreased in the presence of green tea and EGCG. These findings indicate that green tea and EGCG inhibit multiple drug transporters in vitro. Further studies are necessary to investigate the effects of green tea on prototoypical substrates of these transporters in humans, in particular on substrates of hepatic uptake transporters (e.g. statins) as well as on P-glycoprotein substrates.","study.pubmedId":26426900,"study.embaseId":null,"study.croIdentifier":"na","study.croInformation":"University of Erlangen Nuremberg","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"This is a study reported in the literature. The data was entered by JS and reviewed by JY.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProductSampleId":null,"study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProduct.binomial":"Camellia sinensis","study.naturalProduct.name":"Green tea","study.naturalProduct.itis":null,"study.naturalProduct.srs":"e9698137-24da-46f8-a70e-43e27691491f","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":35,"testSystem.name":"Caco-2 cells","testSystem.sortOrder":0,"testSystem.conceptId":null,"testSystem.categoryId":1,"testSystem.category.id":1,"testSystem.category.name":"Cell system","testSystem.category.sortOrder":1,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":87,"controlDataExperiment.uid":"NPDI-wur44g","controlDataExperiment.name":"P-gp mediated digoxin transport in Caco-2 cells","controlDataExperiment.overallEffect":1,"controlDataExperiment.isControlData":true,"controlDataExperiment.isIc50Shift":false,"controlDataExperiment.croCutoff":"NA","controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":"Digoxin transport in Caco-2 cells was greater in the B-A direction compared to in the A-B direction (3.2%/h vs. 0.74%/h). In the presence of the P-go inhibitor zosquidar (1 µM), net efflux of digoxin was completely inhibited.","controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":15,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":10,"controlDataExperiment.experimentTypeId":7,"controlDataExperiment.testSystemId":35,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":7,"controlDataExperiment.experimentType.name":"In Vitro Transporter Kinetics","controlDataExperiment.experimentType.isInVitro":true,"controlDataExperiment.experimentType.isTransporter":true,"controlDataExperiment.experimentType.isEnzyme":false,"controlDataExperiment.experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00005003","controlDataExperiment.objectCompound.id":15,"controlDataExperiment.objectCompound.name":"digoxin","controlDataExperiment.objectCompound.unii":"73K4184T59","controlDataExperiment.objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":1326303,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":11,"controlDataExperiment.transporters.name":"P-gp (ABCB1)","controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":11,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":3976,"experimentAnswers.text":"1 µM","experimentAnswers.answerId":null,"experimentAnswers.experimentId":96,"experimentAnswers.questionId":15,"experimentAnswers.question.id":15,"experimentAnswers.question.text":"Precipitant concentrations tested","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":96,"uid":"NPDI-6qDdNA","name":"Inhibition of P-gp by (-)epigallocatecin gallate","overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"NA","croIdentifier":null,"comment":null,"experimentalConditionsComment":null,"resultsComment":"In the presence of (-)-epigallocatechin gallate, the B-A transport of digoxin significantly decreased from 3.2%/h to 1.6%/h (P < 0.01 to 0.001). In the presence of (-)-epigallocatechin gallate, the B-A transport was greater than the A-B transport.","internalComment":null,"objectCompoundId":15,"objectMetaboliteCompoundId":null,"precipitantCompoundId":37,"cytochromeB5Id":null,"studyId":10,"experimentTypeId":5,"testSystemId":35,"ic50ShiftExperimentId":null,"controlDataExperimentId":87,"controlDataForExperimentId":87,"naturalProductSampleId":null,"experimentType.id":5,"experimentType.name":"In Vitro Transporter Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":true,"experimentType.isEnzyme":false,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000060","objectCompound.id":15,"objectCompound.name":"digoxin","objectCompound.unii":"73K4184T59","objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1326303,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1326303,"objectCompound.concept.conceptName":"Digoxin","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3407","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":37,"precipitantCompound.name":"(-)-epigallocatechin gallate","precipitantCompound.unii":null,"precipitantCompound.inChIKey":null,"precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":19,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":null,"objectMetaboliteCompound.name":null,"objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":null,"objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":null,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":null,"objectMetaboliteCompound.concept.conceptName":null,"objectMetaboliteCompound.concept.domainId":null,"objectMetaboliteCompound.concept.vocabularyId":null,"objectMetaboliteCompound.concept.conceptClassId":null,"objectMetaboliteCompound.concept.standardConcept":null,"objectMetaboliteCompound.concept.conceptCode":null,"objectMetaboliteCompound.concept.validStartDate":null,"objectMetaboliteCompound.concept.validEndDate":null,"objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":null,"enzymes.name":null,"enzymes.conceptId":null,"enzymes.experiment_enzyme_xref.enzymeId":null,"enzymes.experiment_enzyme_xref.experimentId":null,"transporters.id":11,"transporters.name":"P-gp (ABCB1)","transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":96,"transporters.experiment_transporter_xref.transporterId":11,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":10,"study.uid":"NPDI-7LwuzA","study.name":"Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein","study.napdiIdentifier":"PMID:26426900","study.overallSummary":"Green tea catechins inhibit the function of organic anion transporting polypeptides (OATPs) that mediate the uptake of a diverse group of drugs and endogenous compounds into cells. The present study was aimed at investigating the effect of green tea and its most abundant catechin epigallocatechin gallate (EGCG) on the transport activity of several drug transporters expressed in enterocytes, hepatocytes and renal proximal tubular cells such as OATPs, organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), and P-glycoprotein (P-gp). Uptake of the typical substrates metformin for OCTs and MATEs and bromosulphophthalein (BSP) and atorvastatin for OATPs was measured in the absence and presence of a commercially available green tea and EGCG. Transcellular transport of digoxin, a typical substrate of P-gp, was measured over 4 hours in the absence and presence of green tea or EGCG in Caco-2 cell monolayers. OCT1-, OCT2-, MATE1- and MATE2-K-mediated metformin uptake was significantly reduced in the presence of green tea and EGCG (P < 0.05). BSP net uptake by OATP1B1 and OATP1B3 was inhibited by green tea [IC50 2.6% (v/v) and 0.39% (v/v), respectively]. Green tea also inhibited OATP1B1- and OATP1B3-mediated atorvastatin net uptake with IC50 values of 1.9% (v/v) and 1.0% (v/v), respectively. Basolateral to apical transport of digoxin was significantly decreased in the presence of green tea and EGCG. These findings indicate that green tea and EGCG inhibit multiple drug transporters in vitro. Further studies are necessary to investigate the effects of green tea on prototoypical substrates of these transporters in humans, in particular on substrates of hepatic uptake transporters (e.g. statins) as well as on P-glycoprotein substrates.","study.pubmedId":26426900,"study.embaseId":null,"study.croIdentifier":"na","study.croInformation":"University of Erlangen Nuremberg","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"This is a study reported in the literature. The data was entered by JS and reviewed by JY.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProductSampleId":null,"study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProduct.binomial":"Camellia sinensis","study.naturalProduct.name":"Green tea","study.naturalProduct.itis":null,"study.naturalProduct.srs":"e9698137-24da-46f8-a70e-43e27691491f","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":35,"testSystem.name":"Caco-2 cells","testSystem.sortOrder":0,"testSystem.conceptId":null,"testSystem.categoryId":1,"testSystem.category.id":1,"testSystem.category.name":"Cell system","testSystem.category.sortOrder":1,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":87,"controlDataExperiment.uid":"NPDI-wur44g","controlDataExperiment.name":"P-gp mediated digoxin transport in Caco-2 cells","controlDataExperiment.overallEffect":1,"controlDataExperiment.isControlData":true,"controlDataExperiment.isIc50Shift":false,"controlDataExperiment.croCutoff":"NA","controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":"Digoxin transport in Caco-2 cells was greater in the B-A direction compared to in the A-B direction (3.2%/h vs. 0.74%/h). In the presence of the P-go inhibitor zosquidar (1 µM), net efflux of digoxin was completely inhibited.","controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":15,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":10,"controlDataExperiment.experimentTypeId":7,"controlDataExperiment.testSystemId":35,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":7,"controlDataExperiment.experimentType.name":"In Vitro Transporter Kinetics","controlDataExperiment.experimentType.isInVitro":true,"controlDataExperiment.experimentType.isTransporter":true,"controlDataExperiment.experimentType.isEnzyme":false,"controlDataExperiment.experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00005003","controlDataExperiment.objectCompound.id":15,"controlDataExperiment.objectCompound.name":"digoxin","controlDataExperiment.objectCompound.unii":"73K4184T59","controlDataExperiment.objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":1326303,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":11,"controlDataExperiment.transporters.name":"P-gp (ABCB1)","controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":11,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":3977,"experimentAnswers.text":"Prof. Toshiyuki Kan (Department of Synthetic Organic and Medicinal Chemistry, University of Shizuoka, Japan)","experimentAnswers.answerId":null,"experimentAnswers.experimentId":96,"experimentAnswers.questionId":26,"experimentAnswers.question.id":26,"experimentAnswers.question.text":"Precipitant source","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":96,"uid":"NPDI-6qDdNA","name":"Inhibition of P-gp by (-)epigallocatecin gallate","overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"NA","croIdentifier":null,"comment":null,"experimentalConditionsComment":null,"resultsComment":"In the presence of (-)-epigallocatechin gallate, the B-A transport of digoxin significantly decreased from 3.2%/h to 1.6%/h (P < 0.01 to 0.001). In the presence of (-)-epigallocatechin gallate, the B-A transport was greater than the A-B transport.","internalComment":null,"objectCompoundId":15,"objectMetaboliteCompoundId":null,"precipitantCompoundId":37,"cytochromeB5Id":null,"studyId":10,"experimentTypeId":5,"testSystemId":35,"ic50ShiftExperimentId":null,"controlDataExperimentId":87,"controlDataForExperimentId":87,"naturalProductSampleId":null,"experimentType.id":5,"experimentType.name":"In Vitro Transporter Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":true,"experimentType.isEnzyme":false,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000060","objectCompound.id":15,"objectCompound.name":"digoxin","objectCompound.unii":"73K4184T59","objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1326303,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1326303,"objectCompound.concept.conceptName":"Digoxin","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3407","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":37,"precipitantCompound.name":"(-)-epigallocatechin gallate","precipitantCompound.unii":null,"precipitantCompound.inChIKey":null,"precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":19,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":null,"objectMetaboliteCompound.name":null,"objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":null,"objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":null,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":null,"objectMetaboliteCompound.concept.conceptName":null,"objectMetaboliteCompound.concept.domainId":null,"objectMetaboliteCompound.concept.vocabularyId":null,"objectMetaboliteCompound.concept.conceptClassId":null,"objectMetaboliteCompound.concept.standardConcept":null,"objectMetaboliteCompound.concept.conceptCode":null,"objectMetaboliteCompound.concept.validStartDate":null,"objectMetaboliteCompound.concept.validEndDate":null,"objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":null,"enzymes.name":null,"enzymes.conceptId":null,"enzymes.experiment_enzyme_xref.enzymeId":null,"enzymes.experiment_enzyme_xref.experimentId":null,"transporters.id":11,"transporters.name":"P-gp (ABCB1)","transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":96,"transporters.experiment_transporter_xref.transporterId":11,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":10,"study.uid":"NPDI-7LwuzA","study.name":"Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein","study.napdiIdentifier":"PMID:26426900","study.overallSummary":"Green tea catechins inhibit the function of organic anion transporting polypeptides (OATPs) that mediate the uptake of a diverse group of drugs and endogenous compounds into cells. The present study was aimed at investigating the effect of green tea and its most abundant catechin epigallocatechin gallate (EGCG) on the transport activity of several drug transporters expressed in enterocytes, hepatocytes and renal proximal tubular cells such as OATPs, organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), and P-glycoprotein (P-gp). Uptake of the typical substrates metformin for OCTs and MATEs and bromosulphophthalein (BSP) and atorvastatin for OATPs was measured in the absence and presence of a commercially available green tea and EGCG. Transcellular transport of digoxin, a typical substrate of P-gp, was measured over 4 hours in the absence and presence of green tea or EGCG in Caco-2 cell monolayers. OCT1-, OCT2-, MATE1- and MATE2-K-mediated metformin uptake was significantly reduced in the presence of green tea and EGCG (P < 0.05). BSP net uptake by OATP1B1 and OATP1B3 was inhibited by green tea [IC50 2.6% (v/v) and 0.39% (v/v), respectively]. Green tea also inhibited OATP1B1- and OATP1B3-mediated atorvastatin net uptake with IC50 values of 1.9% (v/v) and 1.0% (v/v), respectively. Basolateral to apical transport of digoxin was significantly decreased in the presence of green tea and EGCG. These findings indicate that green tea and EGCG inhibit multiple drug transporters in vitro. Further studies are necessary to investigate the effects of green tea on prototoypical substrates of these transporters in humans, in particular on substrates of hepatic uptake transporters (e.g. statins) as well as on P-glycoprotein substrates.","study.pubmedId":26426900,"study.embaseId":null,"study.croIdentifier":"na","study.croInformation":"University of Erlangen Nuremberg","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"This is a study reported in the literature. The data was entered by JS and reviewed by JY.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProductSampleId":null,"study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProduct.binomial":"Camellia sinensis","study.naturalProduct.name":"Green tea","study.naturalProduct.itis":null,"study.naturalProduct.srs":"e9698137-24da-46f8-a70e-43e27691491f","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":35,"testSystem.name":"Caco-2 cells","testSystem.sortOrder":0,"testSystem.conceptId":null,"testSystem.categoryId":1,"testSystem.category.id":1,"testSystem.category.name":"Cell system","testSystem.category.sortOrder":1,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":87,"controlDataExperiment.uid":"NPDI-wur44g","controlDataExperiment.name":"P-gp mediated digoxin transport in Caco-2 cells","controlDataExperiment.overallEffect":1,"controlDataExperiment.isControlData":true,"controlDataExperiment.isIc50Shift":false,"controlDataExperiment.croCutoff":"NA","controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":"Digoxin transport in Caco-2 cells was greater in the B-A direction compared to in the A-B direction (3.2%/h vs. 0.74%/h). In the presence of the P-go inhibitor zosquidar (1 µM), net efflux of digoxin was completely inhibited.","controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":15,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":10,"controlDataExperiment.experimentTypeId":7,"controlDataExperiment.testSystemId":35,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":7,"controlDataExperiment.experimentType.name":"In Vitro Transporter Kinetics","controlDataExperiment.experimentType.isInVitro":true,"controlDataExperiment.experimentType.isTransporter":true,"controlDataExperiment.experimentType.isEnzyme":false,"controlDataExperiment.experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00005003","controlDataExperiment.objectCompound.id":15,"controlDataExperiment.objectCompound.name":"digoxin","controlDataExperiment.objectCompound.unii":"73K4184T59","controlDataExperiment.objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":1326303,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":11,"controlDataExperiment.transporters.name":"P-gp (ABCB1)","controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":11,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":3978,"experimentAnswers.text":"transwell plates","experimentAnswers.answerId":null,"experimentAnswers.experimentId":96,"experimentAnswers.questionId":35,"experimentAnswers.question.id":35,"experimentAnswers.question.text":"Plate type","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":96,"uid":"NPDI-6qDdNA","name":"Inhibition of P-gp by (-)epigallocatecin gallate","overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"NA","croIdentifier":null,"comment":null,"experimentalConditionsComment":null,"resultsComment":"In the presence of (-)-epigallocatechin gallate, the B-A transport of digoxin significantly decreased from 3.2%/h to 1.6%/h (P < 0.01 to 0.001). In the presence of (-)-epigallocatechin gallate, the B-A transport was greater than the A-B transport.","internalComment":null,"objectCompoundId":15,"objectMetaboliteCompoundId":null,"precipitantCompoundId":37,"cytochromeB5Id":null,"studyId":10,"experimentTypeId":5,"testSystemId":35,"ic50ShiftExperimentId":null,"controlDataExperimentId":87,"controlDataForExperimentId":87,"naturalProductSampleId":null,"experimentType.id":5,"experimentType.name":"In Vitro Transporter Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":true,"experimentType.isEnzyme":false,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000060","objectCompound.id":15,"objectCompound.name":"digoxin","objectCompound.unii":"73K4184T59","objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1326303,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1326303,"objectCompound.concept.conceptName":"Digoxin","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3407","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":37,"precipitantCompound.name":"(-)-epigallocatechin gallate","precipitantCompound.unii":null,"precipitantCompound.inChIKey":null,"precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":19,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":null,"objectMetaboliteCompound.name":null,"objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":null,"objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":null,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":null,"objectMetaboliteCompound.concept.conceptName":null,"objectMetaboliteCompound.concept.domainId":null,"objectMetaboliteCompound.concept.vocabularyId":null,"objectMetaboliteCompound.concept.conceptClassId":null,"objectMetaboliteCompound.concept.standardConcept":null,"objectMetaboliteCompound.concept.conceptCode":null,"objectMetaboliteCompound.concept.validStartDate":null,"objectMetaboliteCompound.concept.validEndDate":null,"objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":null,"enzymes.name":null,"enzymes.conceptId":null,"enzymes.experiment_enzyme_xref.enzymeId":null,"enzymes.experiment_enzyme_xref.experimentId":null,"transporters.id":11,"transporters.name":"P-gp (ABCB1)","transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":96,"transporters.experiment_transporter_xref.transporterId":11,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":10,"study.uid":"NPDI-7LwuzA","study.name":"Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein","study.napdiIdentifier":"PMID:26426900","study.overallSummary":"Green tea catechins inhibit the function of organic anion transporting polypeptides (OATPs) that mediate the uptake of a diverse group of drugs and endogenous compounds into cells. The present study was aimed at investigating the effect of green tea and its most abundant catechin epigallocatechin gallate (EGCG) on the transport activity of several drug transporters expressed in enterocytes, hepatocytes and renal proximal tubular cells such as OATPs, organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), and P-glycoprotein (P-gp). Uptake of the typical substrates metformin for OCTs and MATEs and bromosulphophthalein (BSP) and atorvastatin for OATPs was measured in the absence and presence of a commercially available green tea and EGCG. Transcellular transport of digoxin, a typical substrate of P-gp, was measured over 4 hours in the absence and presence of green tea or EGCG in Caco-2 cell monolayers. OCT1-, OCT2-, MATE1- and MATE2-K-mediated metformin uptake was significantly reduced in the presence of green tea and EGCG (P < 0.05). BSP net uptake by OATP1B1 and OATP1B3 was inhibited by green tea [IC50 2.6% (v/v) and 0.39% (v/v), respectively]. Green tea also inhibited OATP1B1- and OATP1B3-mediated atorvastatin net uptake with IC50 values of 1.9% (v/v) and 1.0% (v/v), respectively. Basolateral to apical transport of digoxin was significantly decreased in the presence of green tea and EGCG. These findings indicate that green tea and EGCG inhibit multiple drug transporters in vitro. Further studies are necessary to investigate the effects of green tea on prototoypical substrates of these transporters in humans, in particular on substrates of hepatic uptake transporters (e.g. statins) as well as on P-glycoprotein substrates.","study.pubmedId":26426900,"study.embaseId":null,"study.croIdentifier":"na","study.croInformation":"University of Erlangen Nuremberg","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"This is a study reported in the literature. The data was entered by JS and reviewed by JY.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProductSampleId":null,"study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProduct.binomial":"Camellia sinensis","study.naturalProduct.name":"Green tea","study.naturalProduct.itis":null,"study.naturalProduct.srs":"e9698137-24da-46f8-a70e-43e27691491f","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":35,"testSystem.name":"Caco-2 cells","testSystem.sortOrder":0,"testSystem.conceptId":null,"testSystem.categoryId":1,"testSystem.category.id":1,"testSystem.category.name":"Cell system","testSystem.category.sortOrder":1,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":87,"controlDataExperiment.uid":"NPDI-wur44g","controlDataExperiment.name":"P-gp mediated digoxin transport in Caco-2 cells","controlDataExperiment.overallEffect":1,"controlDataExperiment.isControlData":true,"controlDataExperiment.isIc50Shift":false,"controlDataExperiment.croCutoff":"NA","controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":"Digoxin transport in Caco-2 cells was greater in the B-A direction compared to in the A-B direction (3.2%/h vs. 0.74%/h). In the presence of the P-go inhibitor zosquidar (1 µM), net efflux of digoxin was completely inhibited.","controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":15,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":10,"controlDataExperiment.experimentTypeId":7,"controlDataExperiment.testSystemId":35,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":7,"controlDataExperiment.experimentType.name":"In Vitro Transporter Kinetics","controlDataExperiment.experimentType.isInVitro":true,"controlDataExperiment.experimentType.isTransporter":true,"controlDataExperiment.experimentType.isEnzyme":false,"controlDataExperiment.experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00005003","controlDataExperiment.objectCompound.id":15,"controlDataExperiment.objectCompound.name":"digoxin","controlDataExperiment.objectCompound.unii":"73K4184T59","controlDataExperiment.objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":1326303,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":11,"controlDataExperiment.transporters.name":"P-gp (ABCB1)","controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":11,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":3979,"experimentAnswers.text":"7","experimentAnswers.answerId":null,"experimentAnswers.experimentId":96,"experimentAnswers.questionId":36,"experimentAnswers.question.id":36,"experimentAnswers.question.text":"Days after plating","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":96,"uid":"NPDI-6qDdNA","name":"Inhibition of P-gp by (-)epigallocatecin gallate","overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"NA","croIdentifier":null,"comment":null,"experimentalConditionsComment":null,"resultsComment":"In the presence of (-)-epigallocatechin gallate, the B-A transport of digoxin significantly decreased from 3.2%/h to 1.6%/h (P < 0.01 to 0.001). In the presence of (-)-epigallocatechin gallate, the B-A transport was greater than the A-B transport.","internalComment":null,"objectCompoundId":15,"objectMetaboliteCompoundId":null,"precipitantCompoundId":37,"cytochromeB5Id":null,"studyId":10,"experimentTypeId":5,"testSystemId":35,"ic50ShiftExperimentId":null,"controlDataExperimentId":87,"controlDataForExperimentId":87,"naturalProductSampleId":null,"experimentType.id":5,"experimentType.name":"In Vitro Transporter Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":true,"experimentType.isEnzyme":false,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000060","objectCompound.id":15,"objectCompound.name":"digoxin","objectCompound.unii":"73K4184T59","objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1326303,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1326303,"objectCompound.concept.conceptName":"Digoxin","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3407","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":37,"precipitantCompound.name":"(-)-epigallocatechin gallate","precipitantCompound.unii":null,"precipitantCompound.inChIKey":null,"precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":19,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":null,"objectMetaboliteCompound.name":null,"objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":null,"objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":null,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":null,"objectMetaboliteCompound.concept.conceptName":null,"objectMetaboliteCompound.concept.domainId":null,"objectMetaboliteCompound.concept.vocabularyId":null,"objectMetaboliteCompound.concept.conceptClassId":null,"objectMetaboliteCompound.concept.standardConcept":null,"objectMetaboliteCompound.concept.conceptCode":null,"objectMetaboliteCompound.concept.validStartDate":null,"objectMetaboliteCompound.concept.validEndDate":null,"objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":null,"enzymes.name":null,"enzymes.conceptId":null,"enzymes.experiment_enzyme_xref.enzymeId":null,"enzymes.experiment_enzyme_xref.experimentId":null,"transporters.id":11,"transporters.name":"P-gp (ABCB1)","transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":96,"transporters.experiment_transporter_xref.transporterId":11,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":10,"study.uid":"NPDI-7LwuzA","study.name":"Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein","study.napdiIdentifier":"PMID:26426900","study.overallSummary":"Green tea catechins inhibit the function of organic anion transporting polypeptides (OATPs) that mediate the uptake of a diverse group of drugs and endogenous compounds into cells. The present study was aimed at investigating the effect of green tea and its most abundant catechin epigallocatechin gallate (EGCG) on the transport activity of several drug transporters expressed in enterocytes, hepatocytes and renal proximal tubular cells such as OATPs, organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), and P-glycoprotein (P-gp). Uptake of the typical substrates metformin for OCTs and MATEs and bromosulphophthalein (BSP) and atorvastatin for OATPs was measured in the absence and presence of a commercially available green tea and EGCG. Transcellular transport of digoxin, a typical substrate of P-gp, was measured over 4 hours in the absence and presence of green tea or EGCG in Caco-2 cell monolayers. OCT1-, OCT2-, MATE1- and MATE2-K-mediated metformin uptake was significantly reduced in the presence of green tea and EGCG (P < 0.05). BSP net uptake by OATP1B1 and OATP1B3 was inhibited by green tea [IC50 2.6% (v/v) and 0.39% (v/v), respectively]. Green tea also inhibited OATP1B1- and OATP1B3-mediated atorvastatin net uptake with IC50 values of 1.9% (v/v) and 1.0% (v/v), respectively. Basolateral to apical transport of digoxin was significantly decreased in the presence of green tea and EGCG. These findings indicate that green tea and EGCG inhibit multiple drug transporters in vitro. Further studies are necessary to investigate the effects of green tea on prototoypical substrates of these transporters in humans, in particular on substrates of hepatic uptake transporters (e.g. statins) as well as on P-glycoprotein substrates.","study.pubmedId":26426900,"study.embaseId":null,"study.croIdentifier":"na","study.croInformation":"University of Erlangen Nuremberg","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"This is a study reported in the literature. The data was entered by JS and reviewed by JY.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProductSampleId":null,"study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProduct.binomial":"Camellia sinensis","study.naturalProduct.name":"Green tea","study.naturalProduct.itis":null,"study.naturalProduct.srs":"e9698137-24da-46f8-a70e-43e27691491f","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":35,"testSystem.name":"Caco-2 cells","testSystem.sortOrder":0,"testSystem.conceptId":null,"testSystem.categoryId":1,"testSystem.category.id":1,"testSystem.category.name":"Cell system","testSystem.category.sortOrder":1,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":87,"controlDataExperiment.uid":"NPDI-wur44g","controlDataExperiment.name":"P-gp mediated digoxin transport in Caco-2 cells","controlDataExperiment.overallEffect":1,"controlDataExperiment.isControlData":true,"controlDataExperiment.isIc50Shift":false,"controlDataExperiment.croCutoff":"NA","controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":"Digoxin transport in Caco-2 cells was greater in the B-A direction compared to in the A-B direction (3.2%/h vs. 0.74%/h). In the presence of the P-go inhibitor zosquidar (1 µM), net efflux of digoxin was completely inhibited.","controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":15,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":10,"controlDataExperiment.experimentTypeId":7,"controlDataExperiment.testSystemId":35,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":7,"controlDataExperiment.experimentType.name":"In Vitro Transporter Kinetics","controlDataExperiment.experimentType.isInVitro":true,"controlDataExperiment.experimentType.isTransporter":true,"controlDataExperiment.experimentType.isEnzyme":false,"controlDataExperiment.experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00005003","controlDataExperiment.objectCompound.id":15,"controlDataExperiment.objectCompound.name":"digoxin","controlDataExperiment.objectCompound.unii":"73K4184T59","controlDataExperiment.objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":1326303,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":11,"controlDataExperiment.transporters.name":"P-gp (ABCB1)","controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":11,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":3980,"experimentAnswers.text":">200 Ω","experimentAnswers.answerId":null,"experimentAnswers.experimentId":96,"experimentAnswers.questionId":38,"experimentAnswers.question.id":38,"experimentAnswers.question.text":"TEER","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":96,"uid":"NPDI-6qDdNA","name":"Inhibition of P-gp by (-)epigallocatecin gallate","overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"NA","croIdentifier":null,"comment":null,"experimentalConditionsComment":null,"resultsComment":"In the presence of (-)-epigallocatechin gallate, the B-A transport of digoxin significantly decreased from 3.2%/h to 1.6%/h (P < 0.01 to 0.001). In the presence of (-)-epigallocatechin gallate, the B-A transport was greater than the A-B transport.","internalComment":null,"objectCompoundId":15,"objectMetaboliteCompoundId":null,"precipitantCompoundId":37,"cytochromeB5Id":null,"studyId":10,"experimentTypeId":5,"testSystemId":35,"ic50ShiftExperimentId":null,"controlDataExperimentId":87,"controlDataForExperimentId":87,"naturalProductSampleId":null,"experimentType.id":5,"experimentType.name":"In Vitro Transporter Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":true,"experimentType.isEnzyme":false,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000060","objectCompound.id":15,"objectCompound.name":"digoxin","objectCompound.unii":"73K4184T59","objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1326303,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1326303,"objectCompound.concept.conceptName":"Digoxin","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3407","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":37,"precipitantCompound.name":"(-)-epigallocatechin gallate","precipitantCompound.unii":null,"precipitantCompound.inChIKey":null,"precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":19,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":null,"objectMetaboliteCompound.name":null,"objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":null,"objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":null,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":null,"objectMetaboliteCompound.concept.conceptName":null,"objectMetaboliteCompound.concept.domainId":null,"objectMetaboliteCompound.concept.vocabularyId":null,"objectMetaboliteCompound.concept.conceptClassId":null,"objectMetaboliteCompound.concept.standardConcept":null,"objectMetaboliteCompound.concept.conceptCode":null,"objectMetaboliteCompound.concept.validStartDate":null,"objectMetaboliteCompound.concept.validEndDate":null,"objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":null,"enzymes.name":null,"enzymes.conceptId":null,"enzymes.experiment_enzyme_xref.enzymeId":null,"enzymes.experiment_enzyme_xref.experimentId":null,"transporters.id":11,"transporters.name":"P-gp (ABCB1)","transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":96,"transporters.experiment_transporter_xref.transporterId":11,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":10,"study.uid":"NPDI-7LwuzA","study.name":"Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein","study.napdiIdentifier":"PMID:26426900","study.overallSummary":"Green tea catechins inhibit the function of organic anion transporting polypeptides (OATPs) that mediate the uptake of a diverse group of drugs and endogenous compounds into cells. The present study was aimed at investigating the effect of green tea and its most abundant catechin epigallocatechin gallate (EGCG) on the transport activity of several drug transporters expressed in enterocytes, hepatocytes and renal proximal tubular cells such as OATPs, organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), and P-glycoprotein (P-gp). Uptake of the typical substrates metformin for OCTs and MATEs and bromosulphophthalein (BSP) and atorvastatin for OATPs was measured in the absence and presence of a commercially available green tea and EGCG. Transcellular transport of digoxin, a typical substrate of P-gp, was measured over 4 hours in the absence and presence of green tea or EGCG in Caco-2 cell monolayers. OCT1-, OCT2-, MATE1- and MATE2-K-mediated metformin uptake was significantly reduced in the presence of green tea and EGCG (P < 0.05). BSP net uptake by OATP1B1 and OATP1B3 was inhibited by green tea [IC50 2.6% (v/v) and 0.39% (v/v), respectively]. Green tea also inhibited OATP1B1- and OATP1B3-mediated atorvastatin net uptake with IC50 values of 1.9% (v/v) and 1.0% (v/v), respectively. Basolateral to apical transport of digoxin was significantly decreased in the presence of green tea and EGCG. These findings indicate that green tea and EGCG inhibit multiple drug transporters in vitro. Further studies are necessary to investigate the effects of green tea on prototoypical substrates of these transporters in humans, in particular on substrates of hepatic uptake transporters (e.g. statins) as well as on P-glycoprotein substrates.","study.pubmedId":26426900,"study.embaseId":null,"study.croIdentifier":"na","study.croInformation":"University of Erlangen Nuremberg","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"This is a study reported in the literature. The data was entered by JS and reviewed by JY.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProductSampleId":null,"study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","study.naturalProduct.binomial":"Camellia sinensis","study.naturalProduct.name":"Green tea","study.naturalProduct.itis":null,"study.naturalProduct.srs":"e9698137-24da-46f8-a70e-43e27691491f","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":35,"testSystem.name":"Caco-2 cells","testSystem.sortOrder":0,"testSystem.conceptId":null,"testSystem.categoryId":1,"testSystem.category.id":1,"testSystem.category.name":"Cell system","testSystem.category.sortOrder":1,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":87,"controlDataExperiment.uid":"NPDI-wur44g","controlDataExperiment.name":"P-gp mediated digoxin transport in Caco-2 cells","controlDataExperiment.overallEffect":1,"controlDataExperiment.isControlData":true,"controlDataExperiment.isIc50Shift":false,"controlDataExperiment.croCutoff":"NA","controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":"Digoxin transport in Caco-2 cells was greater in the B-A direction compared to in the A-B direction (3.2%/h vs. 0.74%/h). In the presence of the P-go inhibitor zosquidar (1 µM), net efflux of digoxin was completely inhibited.","controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":15,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":10,"controlDataExperiment.experimentTypeId":7,"controlDataExperiment.testSystemId":35,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":7,"controlDataExperiment.experimentType.name":"In Vitro Transporter Kinetics","controlDataExperiment.experimentType.isInVitro":true,"controlDataExperiment.experimentType.isTransporter":true,"controlDataExperiment.experimentType.isEnzyme":false,"controlDataExperiment.experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00005003","controlDataExperiment.objectCompound.id":15,"controlDataExperiment.objectCompound.name":"digoxin","controlDataExperiment.objectCompound.unii":"73K4184T59","controlDataExperiment.objectCompound.inChIKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":1326303,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":11,"controlDataExperiment.transporters.name":"P-gp (ABCB1)","controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":11,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":3981,"experimentAnswers.text":"37 deg C","experimentAnswers.answerId":null,"experimentAnswers.experimentId":96,"experimentAnswers.questionId":40,"experimentAnswers.question.id":40,"experimentAnswers.question.text":"Incubation temperature","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null}]